Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
International Journal of Molecular Sciences|March 25, 2022
Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory ConditionsKim Doyon-Laliberté, Matheus Aranguren, Johanne Poudrier, et al.Vaccines|April 3, 2021
The Importance of Regulation in Natural Immunity to HIVLaurence Blondin-Ladrie, Matheus Aranguren, Kim Doyon-Laliberté, et al.Antibodies (Basel, Switzerland)|October 17, 2019
NR4A Expression by Human Marginal Zone B-CellsKim Doyon-Laliberté, Josiane Chagnon-Choquet, Michelle Byrns, et al.Blood|December 1, 2025
NLRP3 inflammasome blockade treats intestinal inflammation associated with chronic granulomatous diseaseEmma Darbinian, Kodjovi D Mlaga, Matheus Aranguren, et al.Viruses|February 26, 2022
Monocyte Gene and Molecular Expression Profiles Suggest Distinct Effector and Regulatory Functions in Beninese HIV Highly Exposed Seronegative Female Commercial Sex WorkersLaurence Blondin-Ladrie, Lyvia Fourcade, Alessandro Modica, et al.Vaccines|January 21, 2023
Subclinical Atherosclerosis Is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in Long-Term HIV Treated IndividualsMatheus Aranguren, Kim Doyon-Laliberté, Mohamed El-Far, et al.International Journal of Molecular Sciences|December 11, 2022
Excess BAFF Alters NR4As Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-Cells in the Context of HIV-1 InfectionKim Doyon-Laliberté, Matheus Aranguren, Michelle Byrns, et al.Current Issues in Molecular Biology|January 26, 2024
Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell PopulationsKim Doyon-Laliberté, Matheus Aranguren, Josiane Chagnon-Choquet, et al.Pageof 1